CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway
Fu Liu,1 Zhi Shangli,1 Zhili Hu2 1The First People’s Hospital of Ziyang, Sichuan, People’s Republic of China; 2The Second Hospital Affiliated to Chongqing Medical University, Chongqing, People’s Republic of China Background: Caveolin-2 (CAV2) is reported to have an im...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-09-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/cav2-promotes-the-growth-of-renal-cell-carcinoma-through-the-egfrpi3ka-peer-reviewed-article-OTT |